Position in EOLS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$17,067,437
-$5,725,867 QoQ
Shares Held
2,459,285
-0.6% QoQ
Ownership
3.72%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#5
of 157 holders
Holding Since
Sep 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PERCEPTIVE ADVISORS LLC holds $274,177,982 across 5 Drug Manufacturers - Specialty & Generic names. EOLS ranks #3 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
8,334,882 | $149,694,480 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
10,308,888 | $103,088,880 | |
| 3 | EOLS |
Evolus, Inc.
This page
|
2,459,285 | $17,067,437 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
467,013 | $3,698,742 | |
| 5 | CPIX |
Cumberland Pharmaceuticals Inc
|
96,982 | $628,443 |
All Filings in EOLS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,067,437 | 2,459,285 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $22,793,304 | 2,474,843 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $56,810,139 | 5,145,846 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $86,777,276 | 5,356,622 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $13,580,221 | 1,485,801 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||